Activity of methylgerambullin from Glycosmis species (Rutaceae) against Entamoeba histolytica and Giardia duodenalis in vitro.


Journal

International journal for parasitology. Drugs and drug resistance
ISSN: 2211-3207
Titre abrégé: Int J Parasitol Drugs Drug Resist
Pays: Netherlands
ID NLM: 101576715

Informations de publication

Date de publication:
08 2019
Historique:
received: 16 11 2018
revised: 06 08 2019
accepted: 09 08 2019
pubmed: 1 9 2019
medline: 19 2 2020
entrez: 1 9 2019
Statut: ppublish

Résumé

Entamoeba histolytica and Giardia duodenalis are widespread intestinal protozoan parasites which both spread via cysts that have to be ingested to infect a new host. Their environment, the small intestine for G. duodenalis and the colon for E. histolytica, contains only very limited amounts of oxygen, so both parasites generate energy by fermentation and substrate level phosphorylation rather than by oxidative phosphorylation. They both contain reducing agents able to reduce and activate nitroimidazole drugs such as metronidazole which is the gold standard drug to treat Entamoeba or Giardia infections. Although metronidazole works well in the majority of cases, it has a number of drawbacks. In animal models, the drug has carcinogenic activity, and concerns about a possible teratogenic activity remain. In addition, the treatment of G. duodenalis infections is hampered by emerging metronidazole resistance. Plant-derived drugs play a dominant role in human medicine, therefore we tested the activity of 14 isolated plant compounds belonging to seven different classes in vitro against both parasites. The tests were performed in a new setting in microtiter plates under anaerobic conditions. The compound with the highest activity was methylgerambullin, a sulphur-containing amide found in Glycosmis species of the family Rutaceae with an EC

Identifiants

pubmed: 31472356
pii: S2211-3207(18)30171-4
doi: 10.1016/j.ijpddr.2019.08.001
pmc: PMC6722286
pii:
doi:

Substances chimiques

Acrylamides 0
Amides 0
Antiprotozoal Agents 0
Plant Extracts 0
Sulfur Compounds 0
methylgerambullin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-117

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Phytochemistry. 2001 May;57(1):57-64
pubmed: 11336261
Molecules. 2012 Oct 31;17(11):12771-91
pubmed: 23114614
Curr Opin Gastroenterol. 2015 Jan;31(1):38-44
pubmed: 25394233
Mutat Res. 2002 Jun;511(2):133-44
pubmed: 12052431
Bioorg Med Chem Lett. 2010 Jan 1;20(1):52-5
pubmed: 19945876
Clin Microbiol Rev. 2001 Jan;14(1):114-28
pubmed: 11148005
Front Physiol. 2012 Nov 28;3:448
pubmed: 23226130
Trans R Soc Trop Med Hyg. 1978;72(4):431-2
pubmed: 212851
Phytochemistry. 2000 May;54(2):207-13
pubmed: 10872212
Int J Antimicrob Agents. 2010 Dec;36(6):570-2
pubmed: 20851577
J Antimicrob Chemother. 2011 May;66(5):1029-35
pubmed: 21393225
J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
N Engl J Med. 2008 Dec 11;359(24):2619-20
pubmed: 19064625
Fortschr Chem Org Naturst. 2000;80:187-223
pubmed: 11036791
Biochim Biophys Acta. 2013 Jun;1830(6):3670-95
pubmed: 23428572
Surgery. 1983 Jan;93(1 Pt 2):165-71
pubmed: 6849201
Lancet. 2003 Mar 22;361(9362):1025-34
pubmed: 12660071
J Surg Res. 1993 Dec;55(6):647-53
pubmed: 8246499
PLoS Biol. 2007 Aug;5(8):e211
pubmed: 17676992
BMJ. 2016 Oct 27;355:i5369
pubmed: 27789441
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Life Sci. 2005 Dec 22;78(5):431-41
pubmed: 16198377
J Biol Chem. 1984 Jul 10;259(13):8252-9
pubmed: 6330106
J Water Health. 2017 Jun;15(3):438-450
pubmed: 28598348
J Biol Chem. 1999 Sep 10;274(37):26051-6
pubmed: 10473552
Vector Borne Zoonotic Dis. 2011 Jul;11(7):793-8
pubmed: 21417924
Clin Microbiol Rev. 2001 Jan;14(1):150-64
pubmed: 11148007
Acta Trop. 2012 Aug;123(2):96-100
pubmed: 22537982
Trans R Soc Trop Med Hyg. 1983;77(4):487-8
pubmed: 6636276
PLoS Negl Trop Dis. 2012;6(6):e1677
pubmed: 22720102
Trop Med Int Health. 2000 Aug;5(8):578-81
pubmed: 10995100
Angew Chem Int Ed Engl. 2016 Aug 22;55(35):10210-26
pubmed: 27488942
Adv Drug Deliv Rev. 2016 Jun 1;101:34-41
pubmed: 27154268
Int J Parasitol Drugs Drug Resist. 2012 May 12;2:166-70
pubmed: 24533278
J Nat Prod. 1996 Dec;59(12):1163-8
pubmed: 9036182
Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):321-327
pubmed: 28910741
J Parasitol. 1977 Oct;63(5):883-6
pubmed: 335035
PLoS Med. 2015 Dec 03;12(12):e1001923
pubmed: 26633896

Auteurs

Mirjana Drinić (M)

Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, A-1090, Vienna, Austria.

Adriane Raninger (A)

Chemodiversity Research Group, Faculty of Life Sciences, University of Vienna, A-1030, Vienna, Austria.

Andrea Zraunig (A)

Chemodiversity Research Group, Faculty of Life Sciences, University of Vienna, A-1030, Vienna, Austria.

Florian Astelbauer (F)

Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, A-1090, Vienna, Austria.

David Leitsch (D)

Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, A-1090, Vienna, Austria.

Andreas Obwaller (A)

Orphanidis Pharma Research GmbH, A-1160, Vienna, Austria; CDMS Clinical Data Management and Statistics GmbH, A-1020, Vienna, Austria.

Julia Walochnik (J)

Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, A-1090, Vienna, Austria.

Harald Greger (H)

Chemodiversity Research Group, Faculty of Life Sciences, University of Vienna, A-1030, Vienna, Austria.

Michael Duchene (M)

Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, A-1090, Vienna, Austria. Electronic address: michael.duchene@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH